Following promising trial data , retatrutide, a novel peptide treatment for addressing adult-onset diabetes , has secured regulatory approval from Great Britain's Medicines and Healthcare Agency ( MHRA https://shopretatrutidepeptide.com/category/retatrutide-peptide/